コンテンツへスキップ
Merck

Asterixis related to gabapentin intake: a case report and review.

Postgraduate medicine (2013-10-12)
Mervat Wahba, Olga Waln
要旨

Asterixis has been reported as a side effect of toxic and metabolic abnormalities. The current literature contains very little evidence of gabapentin-related neurotoxicity. Our observations reveal that neurotoxic side effects of gabapentin use may be seen even when dose adjustments are made for patients with mild-to-moderate renal dysfunction. Clinical vigilance for possible neurotoxic effects of gabapentin therapy in patients with renal dysfunction is warranted.

材料
製品番号
ブランド
製品内容

USP
ガバペンチン, United States Pharmacopeia (USP) Reference Standard
Supelco
ガバペンチン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
ガバペンチン, solid
Supelco
ガバペンチン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
4,4-ペンタメチレン-2-ピロリジノン, Pharmaceutical Secondary Standard; Certified Reference Material